Janssen reports positive results from two Phase III combination trials of Darzalex

Janssen Research& Development has reported positive results from the updated Phase III CASTOR and POLLUX clinical trials of Darzalex (daratumumab) combined with bortezomib and dexamethasone or lenalidomide and dexamethasone to treat patients with mu …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news